FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer

被引:53
作者
Lin, Lilie L.
Yang, Zhiyun
Mutic, Sasa
Miller, Tom R.
Grigsby, Perry W.
机构
[1] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63130 USA
[2] Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO USA
[3] Mallinckrodt Inst Radiol, Dept Radiol, Div Nucl Med, St Louis, MO 63110 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 65卷 / 01期
关键词
positron emission tomography; cervix; FDG-PET; tumor volume;
D O I
10.1016/j.ijrobp.2005.12.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the physiologic tumor volume response during treatment in cervical cancer using 18F-fluorodeoxyglucose positron emission tomography (FDG-PET). Patients and Methods: This was a prospective study of 32 patients. Physiologic tumor volume in cubic centimeters was determined from the FDG-PET images using the 40% threshold method. Results: The mean pretreatment tumor volume was 102 cm(3). The mean volume by clinical Stages I, II, and III were 54, 79, and 176 cm(3), respectively. After 19.8 Gy external irradiation to the pelvis, the reduction in tumor was 29% (72 cm(3)). An additional 13 Gy from high-dose-rate (HDR) brachytherapy reduced the mean to 15.4 cm(3), and this was subsequently reduced to 8.6 cm(3) with 13 Gy additional HDR brachytherapy (26 Gy, HDR). Four patients had physiologic FDG uptake in the cervix at 3 months after the completion of therapy. The mean time to the 50% reduction in physiologic tumor volume was 19.9 days and after combined external irradiation and HDR to 24.9 Gy. Conclusion: These results indicate that physiologic tumor volume determination by FDG-PET is feasible and that a 50% physiologic tumor volume reduction occurs within 20 days of starting therapy. (c) 2006 Elsevier Inc.
引用
收藏
页码:177 / 181
页数:5
相关论文
共 50 条
  • [41] Impact of FDG-PET/CT on radiotherapy volume delineation in non-small-cell lung cancer and correlation of imaging stage with pathologic findings
    Faria, Sergio L.
    Menard, Sonia
    Devic, Slobodan
    Sirois, Christian
    Souhami, Luis
    Lisbona, Robert
    Freeman, Carolyn R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (04): : 1035 - 1038
  • [42] FDG-PET Imaging in Infection and Inflammation
    Kumar, Rakesh
    Nadig, Murali R.
    Balakrishnan, V
    Bal, Chandershekar
    Malhotra, Arun
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2006, 21 (04): : 104 - 113
  • [43] A systematic review of FDG-PET in breast cancer
    Escalona, S.
    Blasco, J. A.
    Reza, M. M.
    Andradas, E.
    Gomez, N.
    MEDICAL ONCOLOGY, 2010, 27 (01) : 114 - 129
  • [44] Interim FDG-PET Imaging in Lymphoma
    Gallamini, Andrea
    Zwarthoed, Colette
    SEMINARS IN NUCLEAR MEDICINE, 2018, 48 (01) : 17 - 27
  • [45] FDG-PET imaging in hematological malignancies
    Valls, L.
    Badve, C.
    Avril, S.
    Herrmann, K.
    Faulhaber, P.
    O'Donnell, J.
    Avril, N.
    BLOOD REVIEWS, 2016, 30 (04) : 317 - 331
  • [46] A systematic review of FDG-PET in breast cancer
    S. Escalona
    J. A. Blasco
    M. M. Reza
    E. Andradas
    N. Gómez
    Medical Oncology, 2010, 27 : 114 - 129
  • [47] Physiologic FDG-PET three-dimensional brachytherapy treatment planning for cervical cancer
    Malyapa, RS
    Mutic, S
    Low, DA
    Zoberi, I
    Bosch, WR
    Laforest, R
    Miller, TR
    Grigsby, PW
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (04): : 1140 - 1146
  • [48] FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy
    Day, F. L.
    Link, E.
    Ngan, S.
    Leong, T.
    Moodie, K.
    Lynch, C.
    Michael, M.
    de Winton, E.
    Hogg, A.
    Hicks, R. J.
    Heriot, A.
    BRITISH JOURNAL OF CANCER, 2011, 105 (04) : 498 - 504
  • [49] Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer
    de Geus-Oei, L. F.
    van Laarhoven, H. W. M.
    Visser, E. P.
    Hermsen, R.
    van Hoorn, B. A.
    Kamm, Y. J. L.
    Krabbe, P. F. M.
    Corstens, F. H. M.
    Punt, C. J. A.
    Oyen, W. J. G.
    ANNALS OF ONCOLOGY, 2008, 19 (02) : 348 - 352
  • [50] Risk Assessment Based on FDG-PET Imaging in Patients with Synovial Sarcoma
    Lisle, Jennifer W.
    Eary, Janet F.
    O'Sullivan, Janet
    Conrad, Ernest U.
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2009, 467 (06) : 1605 - 1611